A cluster randomised trial evaluating the clinical effectiveness and cost of telemedicine delivered multidisciplinary meetings in breast cancer

Completed

• Conditions: Breast cancer; Cancer; Malignant neoplasm of breast

• Registration Number: ISRCTN67592929
• Lead Sponsor: K Department of Health Research and Development

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-11-11
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 230

Inclusion Criteria

1. Histologically proven breast cancer
2. Requiring decision on treatment of primary or recurrent breast cancer

Exclusion Criteria

Does not match inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Satisfaction with communication process of multidisciplinary decision making for each patient (Interpersonal Communication Satisfaction Scale) <br>2. Costs of face-to-face and telemedicine delivered decision making<br>3. Compliance with Scottish Intercollegiate Guidelines Network (SIGN) guidelines of best practice for breast cancer

Secondary Outcome Measures

Name	Time	Method
1. Pre- and post-trial attitudes to face-to-face and telemedicine delivered multidisciplinary clinics (Personal Report of Communication Apprehension)<br>2. Measures of objective patterns of interaction<br>3. Subjective measures of interaction (Group Behaviour Questionnaire, Group Behaviour Inventory, Group Dimensions Description Questionnaire)<br>4. Communication content (Interaction Process Analysis) <br>5. General dimensions of output (satisfaction with communication, group atmosphere, involvement, trust and agreement)